7Baggers
 Published on: 2025-10-02 19:48:50  newser.com Fri, 03 Oct 2025 00:48:50 GMT
 Agios Pharmaceuticals Hits Day High with 9.64% Surge in Stock Price  Markets Mojo Wed, 01 Oct 2025 18:17:08 GMT
 published on: 2025-10-01 06:17:51  newser.com Wed, 01 Oct 2025 11:17:51 GMT
 agios pharmaceuticals hits day high with 9.64% surge in stock price  Markets Mojo Tue, 30 Sep 2025 07:00:00 GMT
 Published on: 2025-09-29 03:46:19  newser.com Mon, 29 Sep 2025 08:46:19 GMT
 Published on: 2025-09-26 15:26:12  newser.com Fri, 26 Sep 2025 20:26:12 GMT
 REMS in spotlight after Agios, Cytokinetics delayed  BioWorld MedTech Wed, 24 Sep 2025 19:42:57 GMT
 beta thalassemia market: insights into epidemiology,  openPR.com Mon, 22 Sep 2025 18:32:04 GMT
 agios drops as fda delays review of thalassemia drug  MSN Thu, 18 Sep 2025 14:54:05 GMT
 agios drops as fda delays review of thalassemia drug  MSN Wed, 17 Sep 2025 09:01:27 GMT
 agios drops as fda delays review of thalassemia drug  MSN Tue, 16 Sep 2025 16:33:03 GMT
 hc wainwright issues pessimistic estimate for agio earnings  MarketBeat Fri, 12 Sep 2025 22:01:25 GMT
 research analysts issue forecasts for agio fy2025 earnings  MarketBeat Fri, 12 Sep 2025 07:00:00 GMT
 hc wainwright has negative outlook for agio fy2025 earnings  MarketBeat Fri, 12 Sep 2025 06:08:48 GMT
 what is hc wainwright's forecast for agio fy2025 earnings?  MarketBeat Tue, 09 Sep 2025 05:44:50 GMT
 agios drops as fda delays review of thalassemia drug  MSN Mon, 08 Sep 2025 16:30:33 GMT
 Biotech Stocks Facing FDA Decision In September 2025  RTTNews Sun, 07 Sep 2025 07:00:00 GMT
 goldman sachs reaffirms their hold rating on agios pharma (agio)  The Globe and Mail Sat, 06 Sep 2025 12:30:00 GMT
 liver injury rems delays us fda approval of agios’s pyrukynd in thalassemia  insights.citeline.com Sat, 06 Sep 2025 00:53:13 GMT
 agios drops as fda delays review of thalassemia drug  MSN Fri, 05 Sep 2025 21:59:50 GMT
 fda extends review period for agios’ thalassemia drug by investing.com  Investing.com Nigeria Fri, 05 Sep 2025 09:33:15 GMT
 treeline expands series a another $200 million  statnews.com Fri, 05 Sep 2025 08:26:15 GMT
 Agios Pharma stock faces FDA delay as PDUFA date extended for Pyrukynd  Investing.com Fri, 05 Sep 2025 07:00:00 GMT
 AGIO Stock Falls as FDA Delays Decision on Pyrukynd for Thalassemia  Yahoo Finance Fri, 05 Sep 2025 07:00:00 GMT
 liver injury rems delays us fda approval of agios’s pyrukynd in thalassemia  insights.citeline.com Fri, 05 Sep 2025 07:00:00 GMT
 mitapivat pdufa for thalassemia delayed to december  HCPLive Thu, 04 Sep 2025 21:04:29 GMT
 bank of america securities remains a buy on agios pharma (agio)  The Globe and Mail Thu, 04 Sep 2025 12:31:00 GMT
 why did agios plunge 26.94%? fda delays pyrukynd review  AInvest Thu, 04 Sep 2025 11:55:52 GMT
 agios drops as fda delays review of thalassemia drug  MSN Thu, 04 Sep 2025 11:49:26 GMT
 FDA pushes back Agios' Pyrukynd thalassemia decision to December  FirstWord Pharma Thu, 04 Sep 2025 07:00:00 GMT
 FDA extends review period for Agios’ thalassemia drug  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 Agios Pharma stock falls as BofA lowers price target on PDUFA delay  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 Agios stock drops as FDA delays Pyrukynd review (AGIO:NASDAQ)  Seeking Alpha Thu, 04 Sep 2025 07:00:00 GMT
 FDA delays decision on Agios drug in thalassemia over liver safety  Endpoints News Thu, 04 Sep 2025 07:00:00 GMT
 Treeline expands Series A another $200 million  statnews.com Thu, 04 Sep 2025 07:00:00 GMT
 liver injury rems delays agios’s pyrukynd us fda approval in thalassemia  insights.citeline.com Thu, 04 Sep 2025 07:00:00 GMT
 agios pharma shares drop amid fda delay concerns  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 td cowen maintains agios pharmaceuticals(agio.us) with buy rating  富途牛牛 Thu, 04 Sep 2025 07:00:00 GMT
 agios pharmaceuticals, inc. $agio shares bought by invesco ltd.  MarketBeat Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 09:41:13  Newser Wed, 03 Sep 2025 14:41:13 GMT
 published on: 2025-08-31 15:38:48  Newser Sun, 31 Aug 2025 20:38:48 GMT
 full technical analysis of agios pharmaceuticals inc. stock  Newser Sun, 31 Aug 2025 19:52:33 GMT
 published on: 2025-08-30 16:42:25  Newser Sat, 30 Aug 2025 21:42:25 GMT

Agios Pharmaceuticals, Inc
(NASDAQ:AGIO) 

AGIO stock logo

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refracto...

Founded: 2008
Full Time Employees: 536
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends